Australia · Delayed Price · Currency is AUD Cochlear Statistics
Total Valuation
Cochlear has a market cap or net worth of AUD 18.98 billion. The enterprise value is 18.94 billion.
| Market Cap | 18.98B |
| Enterprise Value | 18.94B |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
Cochlear has 65.40 million shares outstanding. The number of shares has decreased by -0.17% in one year.
| Current Share Class | 65.40M |
| Shares Outstanding | 65.40M |
| Shares Change (YoY) | -0.17% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 57.42% |
| Float | 65.14M |
Valuation Ratios
The trailing PE ratio is 48.96 and the forward PE ratio is 41.96. Cochlear's PEG ratio is 3.27.
| PE Ratio | 48.96 |
| Forward PE | 41.96 |
| PS Ratio | 8.10 |
| PB Ratio | 9.73 |
| P/TBV Ratio | 13.09 |
| P/FCF Ratio | 108.33 |
| P/OCF Ratio | 79.88 |
| PEG Ratio | 3.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.11, with an EV/FCF ratio of 108.10.
| EV / Earnings | 48.70 |
| EV / Sales | 8.08 |
| EV / EBITDA | 31.11 |
| EV / EBIT | 36.28 |
| EV / FCF | 108.10 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.35 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | 1.35 |
| Interest Coverage | 47.54 |
Financial Efficiency
Return on equity (ROE) is 20.52% and return on invested capital (ROIC) is 15.31%.
| Return on Equity (ROE) | 20.52% |
| Return on Assets (ROA) | 11.73% |
| Return on Invested Capital (ROIC) | 15.31% |
| Return on Capital Employed (ROCE) | 23.53% |
| Revenue Per Employee | 426,018 |
| Profits Per Employee | 70,709 |
| Employee Count | 5,500 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.38 |
Taxes
In the past 12 months, Cochlear has paid 129.60 million in taxes.
| Income Tax | 129.60M |
| Effective Tax Rate | 25.00% |
Stock Price Statistics
The stock price has increased by +1.71% in the last 52 weeks. The beta is 0.39, so Cochlear's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +1.71% |
| 50-Day Moving Average | 291.96 |
| 200-Day Moving Average | 285.95 |
| Relative Strength Index (RSI) | 54.34 |
| Average Volume (20 Days) | 109,413 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cochlear had revenue of AUD 2.34 billion and earned 388.90 million in profits. Earnings per share was 5.93.
| Revenue | 2.34B |
| Gross Profit | 1.73B |
| Operating Income | 522.90M |
| Pretax Income | 518.50M |
| Net Income | 388.90M |
| EBITDA | 573.70M |
| EBIT | 522.90M |
| Earnings Per Share (EPS) | 5.93 |
Balance Sheet
The company has 275.70 million in cash and 235.70 million in debt, giving a net cash position of 40.00 million or 0.61 per share.
| Cash & Cash Equivalents | 275.70M |
| Total Debt | 235.70M |
| Net Cash | 40.00M |
| Net Cash Per Share | 0.61 |
| Equity (Book Value) | 1.95B |
| Book Value Per Share | 29.82 |
| Working Capital | 814.50M |
Cash Flow
In the last 12 months, operating cash flow was 237.60 million and capital expenditures -62.40 million, giving a free cash flow of 175.20 million.
| Operating Cash Flow | 237.60M |
| Capital Expenditures | -62.40M |
| Free Cash Flow | 175.20M |
| FCF Per Share | 2.68 |
Margins
Gross margin is 73.74%, with operating and profit margins of 22.32% and 16.60%.
| Gross Margin | 73.74% |
| Operating Margin | 22.32% |
| Pretax Margin | 22.13% |
| Profit Margin | 16.60% |
| EBITDA Margin | 24.48% |
| EBIT Margin | 22.32% |
| FCF Margin | 7.48% |
Dividends & Yields
This stock pays an annual dividend of 4.30, which amounts to a dividend yield of 1.48%.
| Dividend Per Share | 4.30 |
| Dividend Yield | 1.48% |
| Dividend Growth (YoY) | 4.88% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 71.54% |
| Buyback Yield | 0.17% |
| Shareholder Yield | 1.65% |
| Earnings Yield | 2.05% |
| FCF Yield | 0.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cochlear has an Altman Z-Score of 15.26 and a Piotroski F-Score of 4.
| Altman Z-Score | 15.26 |
| Piotroski F-Score | 4 |